Goodwin Procter advised JMI Equity on the deal. JMI Equity announced its strategic investment, along with Thoma Bravo, in iOFFICE and SpaceIQ. As a result, the two...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Laronde on the deal. Laronde announced its $440 million Series B Financing to advance the development of its eRNA platform and a broad pipeline...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Lead Edge Capital on the deal. Lead Edge Capital led LaunchDarkly’s $200 million in Series D financing. Lead Edge Capital is a growth...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Lowercarbon Capital on the deal. Lowercarbon Capital announced its $800 million fundraise. Lowercarbon Capital is a climate-tech focused fund founded by venture capital veterans...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Goldman Sachs & Co. LLC and the other underwriters on the deal. Omega Therapeutics, Inc. (Nasdaq: OMGA), a development-stage biotechnology company leveraging its OMEGA...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Capital Bay Group on the deal. Capital Bay Group announced the formation of a joint venture with UAE-based Gulf Islamic Investments LLC. Under the...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Baker McKenzie advised Trillium Therapeutics on the deal, while Ropes & Gray LLP and Norton Rose Fulbright Canada represented Pfizer. Trillium Therapeutics (NASDAQ/TSX:...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Hopin on the deal. Hopin, one of the fastest growing startups in Europe, completed its $450 million Series D funding round led by...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Spyce on the deal. sweetgreen, the mission-driven brand serving healthy food at scale, announced its plans to acquire Spyce, the Boston-based restaurant company powered...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Meletios Therapeutics on the deal. Meletios Therapeutics, a French biotechnology company specialized in the research and development of next-generation antiviral treatments, announced a...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised SWORD Health on the deal. SWORD Health announced the completion of its $85 million Series C funding round led by General Catalyst. Other participating...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Vida Ventures on the deal while Goodwin Procter represented Vigil Neuroscience. Vigil Neuroscience, a biotechnology company harnessing the power of...
You must be a Standard 1 Year member to access this content.
